HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SoRI 9409

structure in first source

Also Known As:

5'-(4-chlorophenyl)-17-(cyclopropylmethyl)-6,7-didehydro-3,14-dihydroxy-4,5alpha-epoxypyrido-(2',3'-6,7)morphinan

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Ananthan, S: 2 articles (07/2001 - 05/2001)
2.	Lu, Y F: 1 article (07/2001)
3.	Rice, K C: 1 article (07/2001)
4.	Rothman, R B: 1 article (07/2001)
5.	Xu, H: 1 article (07/2001)
6.	Bartlett, J L: 1 article (05/2001)
7.	Bilsky, E J: 1 article (05/2001)
8.	Wells, J L: 1 article (05/2001)

Related Diseases

1.

Morphine Dependence

07/01/2001 - "Chronic administration of SoRI 9409 to mice failed to produce tolerance to its antinociceptive effect and SoRI 9409 produced less withdrawal signs than naloxone in acute and chronic morphine dependence models. "
05/01/2001 - "SoRI 9409 (10 mg/kg i.p.) elicited much less vertical jumping than naloxone (10 mg/kg i.p.) in acute and chronic morphine dependence models. "

Related Drugs and Biologics

1.	Naloxone (Narcan)